Cardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic Review

Background: Many COVID-19 survivors experience persistent COVID-19 related cardiac abnormalities weeks to months after recovery from acute SARS-CoV-2 infection. Non-invasive cardiac magnetic resonance (CMR) imaging is an important tool of choice for clinical diagnosis of cardiac dysfunctions. In thi...

Full description

Bibliographic Details
Main Authors: Montek S Boparai, Benjamin Musheyev, Umair Khan, Tejaswi Koduru, Jared Hinson, Hal A Skopicki, Tim Q Duong
Format: Article
Language:English
Published: IMR Press 2022-11-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/23/12/10.31083/j.rcm2312389
_version_ 1828085590799679488
author Montek S Boparai
Benjamin Musheyev
Umair Khan
Tejaswi Koduru
Jared Hinson
Hal A Skopicki
Tim Q Duong
author_facet Montek S Boparai
Benjamin Musheyev
Umair Khan
Tejaswi Koduru
Jared Hinson
Hal A Skopicki
Tim Q Duong
author_sort Montek S Boparai
collection DOAJ
description Background: Many COVID-19 survivors experience persistent COVID-19 related cardiac abnormalities weeks to months after recovery from acute SARS-CoV-2 infection. Non-invasive cardiac magnetic resonance (CMR) imaging is an important tool of choice for clinical diagnosis of cardiac dysfunctions. In this systematic review, we analyzed the CMR findings and biomarkers of COVID-19 related cardiac sequela after SARS-CoV-2 infection. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA), we conducted a systematic review of studies that assessed COVID-19 related cardiac abnormalities using cardiovascular magnetic resonance imaging. A total of 21 cross-sectional, case-control, and cohort studies were included in the analyses. Results: Ten studies reported CMR results <3 months after SARS-CoV-2 infection and 11 studies >3 months after SARS-CoV-2 infection. Abnormal T1, abnormal T2, elevated extracellular volume, late gadolinium enhancement and myocarditis was reported less frequently in the >3-month studies. Eight studies reported an association between biomarkers and CMR findings. Elevated troponin was associated with CMR pathology in 5/6 studies, C-reactive protein in 3/5 studies, N-terminal pro-brain natriuretic peptide in 1/2 studies, and lactate dehydrogenase and D-dimer in a single study. The rate of myocarditis via CMR was 18% (154/868) across all studies. Most SARS-CoV-2 associated CMR abnormalities resolved over time. Conclusions: There were CMR abnormalities associated with SARS-CoV-2 infection and most abnormalities resolved over time. A panel of cardiac injury and inflammatory biomarkers could be useful in identifying patients who are likely to present with abnormal CMR pathology after COVID-19. Multiple mechanisms are likely responsible for COVID-19 induced cardiac abnormalities.
first_indexed 2024-04-11T04:41:49Z
format Article
id doaj.art-edfa97cc6992479ebef1d1f8095e8775
institution Directory Open Access Journal
issn 1530-6550
language English
last_indexed 2024-04-11T04:41:49Z
publishDate 2022-11-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj.art-edfa97cc6992479ebef1d1f8095e87752022-12-28T05:34:20ZengIMR PressReviews in Cardiovascular Medicine1530-65502022-11-01231238910.31083/j.rcm2312389S1530-6550(22)00744-XCardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic ReviewMontek S Boparai0Benjamin Musheyev1Umair Khan2Tejaswi Koduru3Jared Hinson4Hal A Skopicki5Tim Q Duong6Department of Radiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USARenaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USARenaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USADepartment of Radiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USARenaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USADepartment of Medicine, Division of Cardiology, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY 11794, USADepartment of Radiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USABackground: Many COVID-19 survivors experience persistent COVID-19 related cardiac abnormalities weeks to months after recovery from acute SARS-CoV-2 infection. Non-invasive cardiac magnetic resonance (CMR) imaging is an important tool of choice for clinical diagnosis of cardiac dysfunctions. In this systematic review, we analyzed the CMR findings and biomarkers of COVID-19 related cardiac sequela after SARS-CoV-2 infection. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA), we conducted a systematic review of studies that assessed COVID-19 related cardiac abnormalities using cardiovascular magnetic resonance imaging. A total of 21 cross-sectional, case-control, and cohort studies were included in the analyses. Results: Ten studies reported CMR results <3 months after SARS-CoV-2 infection and 11 studies >3 months after SARS-CoV-2 infection. Abnormal T1, abnormal T2, elevated extracellular volume, late gadolinium enhancement and myocarditis was reported less frequently in the >3-month studies. Eight studies reported an association between biomarkers and CMR findings. Elevated troponin was associated with CMR pathology in 5/6 studies, C-reactive protein in 3/5 studies, N-terminal pro-brain natriuretic peptide in 1/2 studies, and lactate dehydrogenase and D-dimer in a single study. The rate of myocarditis via CMR was 18% (154/868) across all studies. Most SARS-CoV-2 associated CMR abnormalities resolved over time. Conclusions: There were CMR abnormalities associated with SARS-CoV-2 infection and most abnormalities resolved over time. A panel of cardiac injury and inflammatory biomarkers could be useful in identifying patients who are likely to present with abnormal CMR pathology after COVID-19. Multiple mechanisms are likely responsible for COVID-19 induced cardiac abnormalities.https://www.imrpress.com/journal/RCM/23/12/10.31083/j.rcm2312389mrisars-cov-2myocarditispost-acute covid-19 symptomstroponin
spellingShingle Montek S Boparai
Benjamin Musheyev
Umair Khan
Tejaswi Koduru
Jared Hinson
Hal A Skopicki
Tim Q Duong
Cardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic Review
Reviews in Cardiovascular Medicine
mri
sars-cov-2
myocarditis
post-acute covid-19 symptoms
troponin
title Cardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic Review
title_full Cardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic Review
title_fullStr Cardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic Review
title_full_unstemmed Cardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic Review
title_short Cardiac Magnetic Resonance Imaging of COVID-19-Associated Cardiac Sequelae: A Systematic Review
title_sort cardiac magnetic resonance imaging of covid 19 associated cardiac sequelae a systematic review
topic mri
sars-cov-2
myocarditis
post-acute covid-19 symptoms
troponin
url https://www.imrpress.com/journal/RCM/23/12/10.31083/j.rcm2312389
work_keys_str_mv AT monteksboparai cardiacmagneticresonanceimagingofcovid19associatedcardiacsequelaeasystematicreview
AT benjaminmusheyev cardiacmagneticresonanceimagingofcovid19associatedcardiacsequelaeasystematicreview
AT umairkhan cardiacmagneticresonanceimagingofcovid19associatedcardiacsequelaeasystematicreview
AT tejaswikoduru cardiacmagneticresonanceimagingofcovid19associatedcardiacsequelaeasystematicreview
AT jaredhinson cardiacmagneticresonanceimagingofcovid19associatedcardiacsequelaeasystematicreview
AT halaskopicki cardiacmagneticresonanceimagingofcovid19associatedcardiacsequelaeasystematicreview
AT timqduong cardiacmagneticresonanceimagingofcovid19associatedcardiacsequelaeasystematicreview